Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine

Transplantation

Volumn 51, Issue 2, 1991, Pages 486-490

  Kimball, Pamela M ^a   Kerman, Ronald H ^a   Kahan, Barry D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; RAPAMYCIN;

CELL GROWTH; CONFERENCE PAPER; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; PRIORITY JOURNAL; T LYMPHOCYTE;

B-LYMPHOCYTES; CELL CYCLE; CYCLOSPORINS; DNA REPLICATION; DRUG SYNERGISM; HUMAN; IN VITRO; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; POLYENES; SERINE ENDOPEPTIDASES; SIROLIMUS; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0026102058     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199102000-00041     Document Type: Article

References (34)

1. Kasiske BL, Heim-Duthoy K, Rao KV, Awni WM. The relationship between cyclosporine pharmacokinetic parameters and subsequent acute rejection in renal transplant recipients. Transplantation 1988; 46: 716.
2. Rogers AJ, Yoshimura N, Kerman RH, Kahan BD. Immunophar-macodynamic evaluation of cyclosporine-treated renal allograft recipients. Transplantation 1984; 38: 657.
3. Keown PA. Clinical application of therapeutic drug monitoring: optimizing cyclosporine therapy—dose, levels and monitoring. Transplant Proc 1988; 20: 382.
4. Vathsala A, Chou TC, Kahan BD. Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation. Transplantation 1990; 49: 463.
5. Morris RE, Meiser BM. Identification of a new pharmacologic action for an old compound. Med Sci Res 1989; 17: 609.
6. Martel RR, Klicius J, Galet S. Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can J Physiol Pharmacol 1976; 55: 48.
7. Baker H, Sidorowiez A, Sehgal SN, Vezina C. Rapamycin, a new fungal antibiotic. J Antibiot (Tokyo) 1978; 31: 539.
8. Drugge RJ, Handschumacher RE. Cyclosporine—mechansim of action. Transplant Proc 1988; 20: 301.
9. Dumont FJ, Staruch MJ, Koprak SL, Melino MR, Sigal N. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK506 and rapamycin. J Immunol 1990; 144: 251.
10. Omura S, Tanaka H. Production, structure and antifungal activity of polyene macrolides. In: Omura S, ed. Macrolide antibiotics. New York: Academic, 1984: 351.
11. Rosen MK, Standaert RK, Galat A, Nakatsuka M, Schreiber SL. Inhibition of FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate. Nature 1990; 248: 863.
12. Pereira GM, Miller JF, Shevach EM. Mechanism of cyclosporine A in vivo. J Immunol 1990; 144: 2109.
13. Clerici M, Shearer GM. Differential sensitivity of human T helper cell pathways by in vitro exposure to cyclosporine A. J Immunol 1990; 144: 2480.
14. Kimball PM, Gamaz N, Sell S. Resting lymhocytes are the target of cyclosporin action. Diabetes Res 1988; 7: 113.
15. Kumagai N, Benedict SH, Mills GB, Gelfand EW. Cyclosporin A inhibits initiation but not progression of human T cell proliferation triggered by phorbol esters and calcium ionophores. J Immunol 1988; 141: 3752.
16. Hess AD, Esa AH, Colombani PM. Mechanism of action of cyclosporine: effect on cells of the immune system and on sub-cellular events in T cell activation. Transplant Proc 1988; 20: 29.
17. Colombani PM, Bright EC, Wells M, Hess AD. Drug-drug interaction between cyclosporine and agents affecting calcium-dependent lymphocyte proliferation. Transplant Proc 1989; 21:840.
18. Citterio F, Kahan B. Effects of cyclosporine on nuclear function. Transplant Proc 1988; 20: 75.
19. Citterio F, Kahan B. Cyclosporine’s dual mechanism of action to inhibit both generation of the cytoplasmic activation signal and the nuclear response thereto. Transplantation (in press).
20. Citterio F, Kahan BD. The inhibitory effect of cyclosporine on the nuclear proliferative response to a variety of T cell activators. Transplantation 1989; 47: 334.
21. Kimball PK, Kerman RH, Kahan BD. Sensitivity of intracellular signals responsible for cell cycle progression to cyclosporine. Transplantation 1990; 49: 186.
22. Gutowski JK, Cohen S. Induction of DNA synthesis in isolated nuclei by cytoplasmic factors from spontaneously proliferating and mitogen-activated lymphoid cells. Cell Immunol 1983; 75: 300.
23. Wong RL, Gutowski JK, Katz M, Goldfarb RH, Cohen S. Induction of DNA synthesis in isolated nuclei by cytoplasmic factors: inhibition by protease inhibitors. Proc Natl Acad Sci USA 1987; 84: 241.
24. Yoshimura N, Matsui S, Hamashima T, Oka T. Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. Transplantation 1988; 47: 351.
25. Stephen M, Woo J, Hasan NU, Whiting PH, Thomson AW. Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK506 in the rat. Transplantation 1989; 47: 60.
26. Furue M, Kawakami Y, Kawakami T, Katz SI. Differential inhibition of the T-cell activation pathway by dexamethasone and cyclosporine. Transplantation 1990; 49: 560.
27. Metcalf SM, Richards FM. Cyclosporine, FK506, and rapamycin: some effects on early activation events in serum-free, mitogen- stimulation mouse spleen cells. Transplantation 1990; 49: 798.
28. Kimball PM, Sell S. Cyclosporin immunosuppression mediated by calcium/sodium imbalance. Cancer Res 1989; 49: 877.
29. Kimball PM, Gamaz N, Sell S. Two episodes of calcium uptake associated with T-lymphocyte activation. Cell Immunol 1988; 113: 107.
30. Lillie JW, Green MR. Activator’s target in sight. Nature 1989; 341: 279.
31. Fischer G, Wittmann-Liebold B, Lang K, Kiefhaber T, Schmid FX. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 1989; 337: 476.
32. Lang K, Schmid FX. Protein-disulphide isomerase and prolyl isomerase act differently and independently as catalysts of protein folding. Nature 1989; 331: 453.
33. Sierkierka JJ, Hung S, Poe M, Lin C, Sigal N. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 1989; 341: 755.
34. Harding M, Galat A, Uehling D, Schreiber S. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 1989; 341: 758.